Development of Therapeutic Medical Countermeasures for Biodefense and Emerging Infectious Diseases
Contract Overview
Contract Amount: $28,199,896 ($28.2M)
Contractor: Venatorx Pharmaceuticals Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2013-09-16
End Date: 2019-09-30
Contract Duration: 2,205 days
Daily Burn Rate: $12.8K/day
Official Description: IGF::OT::IGF DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES
Place of Performance
Location: Pennsylvania, 19355